Replies to post #198943 on Innovation Pharmaceuticals Inc (IPIX)

[frrol]

Note the market cap

[sox040713]

Celsion's result shows a trial with small patient size can have a big impact on the stock price (+300%). In their Phase 1b combo trial, 2/14 patients achieved complete response, 10/14 achieved partial response, 2/14 achieved stable disease. Looking forward to the interim analysis of K-OC this quarter.

Check out CL5N for their phase 1 trial of 14 patients. In Ovarian Cancer.